1H O
and O
15N O
magnetic O
resonance O
assignments O
, O
secondary O
structure O
, O
and O
tertiary O
fold O
of O
Escherichia B
coli I
DnaJ I
( I
1 I
- I
78 I
) I
. O

The O
S B
. I
typhimurium I
aspartyl I
/ I
asparaginyl I
beta I
- I
hydroxylase I
homologue I
( O
designated O
lpxO B
) O
was O
cloned O
into O
pBluescriptSK O
and O
expressed O
in O
Escherichia O
coli O
K O
- O
12 O
, O
which O
does O
not O
contain O
lpxO B
. O

Module O
2 O
of O
RifA B
lacks O
a O
beta B
- I
ketoacyl I
: I
acyl I
carrier I
protein I
reductase I
( O
KR B
) O
domain O
and O
the O
one O
in O
module O
3 O
has O
an O
apparently O
inactive O
NADPH B
binding I
motif I
, O
similar O
to O
one O
found O
in O
the O
Er B
PKS I
, O
while O
the O
other O
eight O
KR B
domains I
of O
the O
Rf B
PKS I
should O
be O
functional O
. O

VAV B
and O
SOCS1 B
form O
a O
protein O
complex O
through O
interactions O
between O
the O
VAV B
NH I
( I
2 I
) I
- I
terminal I
regulatory I
region I
and O
the O
SH2 B
domain I
of O
SOCS1 B
in O
a O
phosphotyrosine O
- O
independent O
manner O
. O

The O
Ras B
GTPase I
- I
activating I
- I
protein I
- I
related I
human I
protein I
IQGAP2 B
harbors O
a O
potential O
actin B
binding I
domain I
and O
interacts O
with O
calmodulin B
and O
Rho B
family I
GTPases I
. O

The O
melanoma B
growth I
stimulatory I
activity I
/ I
growth I
- I
regulated I
protein I
, O
CXCL1 B
, O
is O
constitutively O
expressed O
at O
high O
levels O
during O
inflammation O
and O
progression O
of O
melanocytes O
into O
malignant O
melanoma O
. O

Epstein B
- I
Barr I
virus I
nuclear I
antigen I
2 I
exerts O
its O
transactivating O
function O
through O
interaction O
with O
recombination B
signal I
binding I
protein I
RBP I
- I
J I
kappa I
, O
the O
homologue O
of O
Drosophila B
Suppressor I
of I
Hairless I
. O

Recombinant B
MsERK1 I
( O
rMsERK1 B
) O
, O
when O
overexpressed O
in O
Escherichia O
coli O
, O
is O
recognized O
by O
antibodies O
raised O
against O
MAP B
kinases I
from I
rat I
, I
Xenopus I
, I
and I
sea I
star I
and O
by O
anti B
- I
phosphotyrosine I
antibodies I
. O

A O
minimal O
pheromone O
induction O
domain O
, O
delineated O
as O
residues O
301 O
to O
335 O
of O
Ste12p B
, O
is O
dependent O
on O
the O
pheromone O
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
pathway O
for O
induction O
activity O
. O

This O
fragment O
contains O
two O
complete O
endo B
- I
beta I
- I
1 I
, I
4 I
- I
glucanase I
- I
encoding I
genes I
, O
designated O
celCCC B
and O
celCCG B
. O

After O
Northern O
blot O
hybridization O
, O
two O
Cx31 B
transcripts I
of I
2 I
. I
2 I
and I
1 I
. I
8 I
kb I
were O
detected O
in O
total O
RNA O
of O
the O
human O
keratinocyte O
cell O
line O
HaCaT O
and O
two O
transcripts O
of O
2 O
. O
2 O
and O
1 O
. O
9 O
kb O
in O
total O
RNA O
of O
E6 B
/ O
E7 B
transfected O
human O
keratinocytes O
( O
HEK O
cells O
) O
. O

Phylogenetic O
analysis O
using O
a O
neighbor O
- O
joining O
algorithm O
showed O
closest O
similarity O
of O
the O
horse B
mu I
chain I
- I
encoding I
constant I
region I
gene I
to O
human O
and O
dog O
sequences O
. O

Developmentally O
- O
regulated O
interaction O
of O
a O
transcription O
factor O
complex O
containing O
CDP B
/ O
cut B
with O
the O
early B
histone I
H3 I
gene I
promoter I
of I
the I
sea I
urchin I
Tetrapygus I
niger I
is O
associated O
with O
changes O
in O
chromatin O
structure O
and O
gene O
expression O
. O

Its O
activity O
was O
twice O
that O
of O
a O
construct O
where O
the O
CAT B
gene I
was O
driven O
by O
the O
H B
- I
2Kb I
5 I
' I
enhancer I
region I
( O
H2TF1 B
/ O
KBF1 B
site O
) O
and O
comparable O
to O
that O
of O
pRSVCAT O
construct B
carrying I
the I
strong I
Rous I
sarcoma I
virus I
LTR I
enhancer I
. O

Mouse B
macrophage I
beta I
subunit I
( I
CD11b I
) I
cDNA I
for O
the O
CR3 B
complement I
receptor I
/ O
Mac B
- I
1 I
antigen I
. O

Surprisingly O
, O
apo B
- I
iso I
- I
1 I
- I
cytochrome I
c I
is O
absent O
in O
cyc3 B
- I
strains O
, O
although O
apo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
present O
at O
approximately O
the O
same O
level O
at O
which O
holo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
found O
in O
CYC3 B
+ I
strains O
. O

Surprisingly O
, O
apo B
- I
iso I
- I
1 I
- I
cytochrome I
c I
is O
absent O
in O
cyc3 B
- I
strains O
, O
although O
apo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
present O
at O
approximately O
the O
same O
level O
at O
which O
holo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
found O
in O
CYC3 B
+ I
strains O
. O

Surprisingly O
, O
apo B
- I
iso I
- I
1 I
- I
cytochrome I
c I
is O
absent O
in O
cyc3 B
- I
strains O
, O
although O
apo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
present O
at O
approximately O
the O
same O
level O
at O
which O
holo B
- I
iso I
- I
2 I
- I
cytochrome I
c I
is O
found O
in O
CYC3 B
+ I
strains O
. O

Co O
- O
operativity O
of O
functional O
domains O
in O
the O
muscle B
- I
specific I
transcription I
factor I
Myf I
- I
5 I
. O

Protein B
kinase I
C I
transiently O
activated O
heteromeric B
N I
- I
methyl I
- I
D I
- I
aspartate I
receptor I
channels I
independent O
of O
the O
phosphorylatable O
C O
- O
terminal O
splice O
domain O
and O
of O
consensus O
phosphorylation O
sites O
. O

The O
Caenorhabditis B
elegans I
NK I
- I
2 I
class I
homeoprotein I
CEH I
- I
22 I
is O
involved O
in O
combinatorial O
activation O
of O
gene O
expression O
in O
pharyngeal O
muscle O
. O

The O
transcriptional O
activity O
of O
P B
- I
450 I
( I
11 I
beta I
) I
gene I
was O
studied O
with O
an O
in O
vitro O
transcription O
system O
using O
nuclear O
extracts O
prepared O
from O
bovine O
adrenal O
cortex O
. O

Phenotypic O
screening O
of O
mutations O
in O
Pmr1 B
, O
the O
yeast B
secretory I
pathway I
Ca2 I
+ I
/ I
Mn2 I
+ I
- I
ATPase I
, O
reveals O
residues O
critical O
for O
ion O
selectivity O
and O
transport O
. O

The O
gp41 B
peptide I
( I
Glu I
- I
Leu I
- I
Asp I
- I
Lys I
- I
Trp I
- I
Ala I
) I
fused O
to O
the O
C O
- O
terminus O
of O
Sj B
GST I
forms O
a O
loop O
stabilized O
by O
symmetry O
- O
related O
GSTs B
. O

We O
analyzed O
the O
contribution O
of O
the O
three O
different O
types O
of O
UV O
- O
inducible O
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinases I
( O
ERK B
, O
JNK B
/ O
SAPK B
, O
and O
p38 B
) O
to O
the O
activation O
of O
the O
murine O
uPA B
promoter O
by O
UV O
. O

The O
predicted O
product O
exhibits O
91 O
% O
amino O
acid O
identity O
to O
the O
murine B
voltage I
- I
gated I
potassium I
channel I
protein I
Kv1 I
. I
7 I
( O
Kcna7 B
) O
, O
which O
plays O
an O
important O
role O
in O
the O
repolarization O
of O
cell O
membranes O
. O

Rat B
cholesterol I
side I
- I
chain I
cleavage I
cytochrome I
P I
- I
450 I
( O
P B
- I
450scc I
) O
gene O
. O

It O
is O
also O
affected O
by O
the O
HAP2 B
/ I
3 I
/ I
4 I
transcription I
factor I
complex I
and O
by O
SNF1 B
and O
SSN6 B
. O

Recently O
, O
we O
demonstrated O
that O
platelet B
- I
derived I
growth I
factor I
( I
PDGF I
) I
- I
beta I
receptor I
stimulation O
, O
but O
not O
various O
other O
growth O
factors O
, O
inhibits O
transcription O
of O
alpha1D B
- O
, O
but O
not O
alpha1A B
- O
or O
alpha1B B
- I
ARs I
, O
resulting O
in O
reduced O
norepinephrine O
- O
mediated O
SMC O
growth O
. O

The O
majority O
of O
the O
human B
Ig I
heavy I
chain I
( I
IgH I
) I
constant I
( I
C I
) I
region I
locus I
has O
been O
cloned O
and O
mapped O
. O

Promoter O
, O
spliced O
leader O
, O
and O
coding O
sequence O
for O
BICP4 B
, O
the O
largest O
of O
the O
immediate B
- I
early I
proteins I
of I
bovine I
herpesvirus I
1 I
. O

Since O
simian B
virus I
40 I
( I
SV40 I
) I
large I
T I
antigen I
and O
human B
papillomavirus I
type I
16 I
( I
HPV16 I
) I
E7 I
protein I
also O
bind O
host O
regulatory O
factors O
, O
we O
investigated O
whether O
these O
viral O
proteins O
can O
complement O
E1A B
mutants I
which O
are O
defective O
in O
early O
gene O
activation O
. O

Since O
simian B
virus I
40 I
( I
SV40 I
) I
large I
T I
antigen I
and O
human B
papillomavirus I
type I
16 I
( I
HPV16 I
) I
E7 I
protein I
also O
bind O
host O
regulatory O
factors O
, O
we O
investigated O
whether O
these O
viral O
proteins O
can O
complement O
E1A B
mutants I
which O
are O
defective O
in O
early O
gene O
activation O
. O

Portions O
of O
the O
3 O
' O
- O
coding O
and O
3 O
' O
- O
untranslated O
regions O
were O
found O
to O
be O
missing O
from O
the O
7 B
. I
2 I
- I
and I
4 I
. I
8 I
- I
kb I
topo I
II I
alpha I
mRNAs I
by O
Northern O
blot O
analysis O
. O

We O
have O
isolated O
and O
structurally O
characterized O
genomic O
DNA O
and O
cDNA O
sequences O
encoding O
ribulose B
- I
1 I
, I
5 I
- I
bisphosphate I
carboxylase I
/ I
oxygenase I
( I
Rbu I
- I
P2 I
carboxylase I
) I
activase I
from O
barley O
( O
Hordeum O
vulgare O
L O
. O
) O
. O

The O
2 B
. I
3 I
x I
10 I
( I
3 I
) I
base I
SUF12 I
+ I
transcript I
contains O
an O
open O
reading O
frame O
sufficient O
to O
encode O
a O
88 O
x O
10 O
( O
3 O
) O
Mr O
protein O
. O

This O
ligand O
- O
independent O
pathway O
can O
function O
through O
another O
androgen O
- O
regulated O
promoter O
as O
shown O
by O
the O
use O
of O
the O
mouse B
mammary I
tumor I
virus I
MMTV I
- I
CAT I
reporter I
. O

However O
, O
coligation O
of O
Fc B
gamma I
RIIB1 I
with O
B B
cell I
Ag I
receptors I
( O
BCR B
) O
inhibits O
BCR B
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases B
SHP I
- I
1 I
, O
SHP B
- I
2 I
, O
and O
the O
SH2 B
containing I
inositol I
5 I
' I
phosphatase I
( O
SHIP B
) O
to O
the O
phosphorylated O
Fc B
gamma I
RIIB1 I
immunoreceptor I
tyrosine I
- I
based I
inhibitory I
motif I
. O

Recently O
, O
we O
have O
demonstrated O
that O
mouse O
microglial O
cells O
, O
the O
brain O
macrophages O
, O
express O
both O
IL B
- I
15 I
and O
IL B
- I
15 I
/ I
IL I
- I
2 I
receptors I
. O

A O
5789 B
- I
nucleotide I
- I
long I
EcoRI I
fragment I
from O
the O
genome O
of O
Thermotoga O
maritima O
, O
identified O
by O
cross O
- O
hybridization O
to O
L11 B
, O
L1 B
, O
L10 B
, O
and O
L12 B
ribosomal I
protein I
gene I
sequences I
from I
Escherichia I
coli I
, O
was O
cloned O
and O
sequenced O
. O

Binding O
of O
C B
/ I
EBPs I
to O
all O
three O
spi B
2 I
. I
3 I
3 I
' I
UTR I
repressor I
sites I
, O
although O
rather O
weak O
, O
was O
confirmed O
by O
electrophoretic O
mobility O
shift O
assays O
that O
otherwise O
failed O
to O
reveal O
specific O
interactions O
with O
other O
liver O
nuclear O
proteins O
in O
vitro O
. O

The O
P B
- I
ITIM I
- I
compelled I
multi I
- I
phosphoprotein I
complex I
binds O
to O
and O
activates O
SHP B
- I
2 I
, O
which O
in O
turn O
dephosphorylates O
SHIP B
and O
Shc B
and O
probably O
other O
substrates O
. O

The O
enzyme O
encoded O
by O
the O
cloned O
fragment O
is O
equally O
active O
on O
pyruvate O
and O
hydroxypyruvate O
, O
indicating O
that O
the O
enzyme O
has O
both O
D B
- I
lactate I
and I
D I
- I
glycerate I
dehydrogenase I
activities O
. O

The O
prevalence O
of O
antibodies O
to O
HRES B
- I
1 I
peptides I
pep14 I
- I
24 I
and I
pep117 I
- I
127 I
was O
determined O
in O
65 O
normal O
blood O
donors O
and O
146 O
patients O
with O
immunological O
disorders O
. O

Inspection O
of O
X B
. I
tropicalis I
, I
mouse I
and I
human I
U6 I
DNA I
upstream I
sequences I
revealed O
the O
presence O
of O
a O
TATA O
box O
as O
well O
as O
of O
the O
proximal O
and O
enhancer O
( O
octamer O
motif O
) O
elements O
contained O
in O
snRNA O
genes O
transcribed O
by O
RNA B
polymerase I
II I
. O

Human B
and I
murine I
cytotoxic I
T I
lymphocyte I
serine I
proteases I
: O
subsite O
mapping O
with O
peptide O
thioester O
substrates O
and O
inhibition O
of O
enzyme O
activity O
and O
cytolysis O
by O
isocoumarins O
. O

These O
cDNAs O
were O
found O
to O
be O
derived O
from O
the O
3 O
" O
- O
untranslated O
region O
( O
3 O
" O
- O
UTR O
) O
of O
the O
methyl B
- I
CpG I
- I
binding I
protein I
2 I
gene I
( O
MeCP2 B
) O
. O

As O
a O
test O
of O
this O
hypothesis O
, O
we O
predicted O
that O
mice O
which O
have O
altered O
expression O
of O
class O
I O
gene O
products O
, O
the O
beta2 B
- I
microglobulin I
knockout O
mice O
, O
[ B
beta2m I
( I
- I
/ I
- I
) I
] I
, O
would O
develop O
Fe O
overload O
. O

Using O
the O
conflict O
drinking O
test O
as O
a O
model O
, O
we O
studied O
in O
rats O
the O
effect O
of O
the O
nonselective O
beta B
- I
adrenoceptor I
blockers O
pindolol O
and O
cyanopindolol O
which O
bind O
to O
5 B
- I
HT1A I
and I
5 I
- I
HT1B I
receptors I
, O
and O
of O
the O
selective O
beta B
1 I
- I
and I
beta I
2 I
- I
adrenoceptor I
antagonists O
betaxolol O
and O
ICI O
118 O
, O
551 O
, O
respectively O
, O
which O
have O
a O
negligible O
affinity O
for O
5 B
- I
HT I
receptors I
. O

Using O
the O
conflict O
drinking O
test O
as O
a O
model O
, O
we O
studied O
in O
rats O
the O
effect O
of O
the O
nonselective O
beta B
- I
adrenoceptor I
blockers O
pindolol O
and O
cyanopindolol O
which O
bind O
to O
5 B
- I
HT1A I
and I
5 I
- I
HT1B I
receptors I
, O
and O
of O
the O
selective O
beta B
1 I
- I
and I
beta I
2 I
- I
adrenoceptor I
antagonists O
betaxolol O
and O
ICI O
118 O
, O
551 O
, O
respectively O
, O
which O
have O
a O
negligible O
affinity O
for O
5 B
- I
HT I
receptors I
. O

Rhinovirus B
2A I
protease I
and O
foot B
- I
and I
- I
mouth I
- I
disease I
virus I
L I
protease I
were O
used O
to O
analyze O
the O
association O
of O
eIF4G B
with O
eIF4A B
, O
eIF4E B
, O
and O
eIF3 B
. O

In O
EGF B
receptor I
- O
mediated O
signaling O
, O
the O
protein B
kinase I
PKB I
/ O
Akt B
and O
the O
mitogen B
- I
activated I
protein I
kinase I
c I
- I
Jun I
N I
- I
terminal I
kinase I
, O
but O
not O
extracellular B
signal I
- I
regulated I
kinase I
2 I
, O
function O
downstream O
of O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

Molecular O
analysis O
indicated O
that O
inactivation O
of O
H B
- I
2L I
expression O
in O
nearly O
every O
null O
clone O
resulted O
from O
an O
apparent O
deletion O
or O
rearrangement O
of O
5 B
' I
- I
flanking I
and I
5 I
' I
- I
coding I
H I
- I
2L I
sequences I
, O
with O
breakpoints O
consistently O
mapping O
to O
within O
a O
550 O
bp O
GC O
- O
rich O
region O
between O
exon O
1 O
and O
the O
middle O
of O
intron O
2 O
. O

We O
have O
now O
isolated O
cDNA O
for O
an O
invertebrate B
Pax I
- I
6 I
protein I
from I
sea I
urchin I
embryos I
. O

The O
sequence O
of O
the O
127 B
residue I
NrfF I
polypeptide I
, I
M I
( I
r I
) I
14 I
, I
522 I
, O
is O
strikingly O
similar O
to O
the O
CcI2 B
protein I
of O
R O
. O
capsulatus O
, O
especially O
in O
the O
putative O
haem O
- O
binding O
motif O
, O
RCPQCQNQN O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Subtype O
- O
and O
response O
element O
- O
dependent O
differences O
in O
transactivation O
by O
peroxisome B
proliferator I
- I
activated I
receptors I
alpha I
and I
gamma I
. O

Plasmid O
subclones O
of O
the O
hr1a B
- O
containing O
AcMNPV O
HindIII B
- O
N O
fragment O
were O
examined O
for O
their O
ability O
to O
replicate O
in O
virus O
- O
infected O
( O
Spodoptera O
frugiperda O
) O
Sf9 O
cells O
, O
and O
to O
stimulate O
transcription O
when O
linked O
in O
cis O
with O
a O
39K B
gene I
promoter I
- I
beta I
- I
glucuronidase I
fusion I
and O
cotransfected O
into O
cells O
along O
with O
a O
plasmid O
( O
ple O
- O
1 O
) O
containing O
the O
gene O
encoding O
the O
trans O
- O
acting O
factor O
IE B
- I
1 I
. O

Here O
, O
we O
describe O
the O
crystal O
structure O
at O
2 O
. O
5 O
A O
resolution O
of O
a O
fragment O
of O
the O
integrase B
of I
Rous I
sarcoma I
virus I
( I
residues I
49 I
- I
286 I
) I
containing O
both O
the O
conserved O
catalytic O
domain O
and O
a O
modulatory O
DNA O
- O
binding O
domain O
( O
C O
domain O
) O
. O

The O
B B
. I
aphidicola I
argS I
- I
rrn I
DNA I
fragments I
from O
endosymbionts O
from O
seven O
species O
of O
aphids O
had O
promoter O
activities O
in O
E O
. O
coli O
which O
ranged O
from O
6 O
to O
135 O
% O
of O
that O
observed O
with O
a O
comparable O
DNA O
fragment O
of O
E B
. I
coli I
rrnB I
. O

Role O
of O
the O
CCAAT B
/ I
enhancer I
binding I
protein I
- I
alpha I
transcription I
factor I
in O
the O
glucocorticoid O
stimulation O
of O
p21waf1 B
/ O
cip1 B
gene O
promoter O
activity O
in O
growth O
- O
arrested O
rat O
hepatoma O
cells O
. O

MDA O
- O
MB O
- O
468 O
cells O
were O
stably O
transfected O
with O
either O
a O
plasmid O
having O
a O
CMV B
promoter I
- O
driven O
rabbit B
beta I
- I
globin I
gene I
or O
plasmids O
having O
a O
CMV B
promoter I
- O
driven O
chimeric O
gadd45 B
5 O
" O
- O
UTR O
- O
rabbit B
beta I
- I
globin I
gene O
, O
where O
the O
entire B
gadd45 I
5 I
" I
- I
UTR I
( I
from I
+ I
1 I
to I
+ I
298 I
) I
or O
a O
45 O
bp O
subfragment O
of O
the O
gadd45 B
5 I
" I
- I
UTR I
( I
from I
+ I
10 I
to I
+ I
55 I
) I
was O
positioned O
at O
the O
5 O
" O
- O
end O
of O

MDA O
- O
MB O
- O
468 O
cells O
were O
stably O
transfected O
with O
either O
a O
plasmid O
having O
a O
CMV B
promoter I
- O
driven O
rabbit B
beta I
- I
globin I
gene I
or O
plasmids O
having O
a O
CMV B
promoter I
- O
driven O
chimeric O
gadd45 B
5 O
" O
- O
UTR O
- O
rabbit B
beta I
- I
globin I
gene O
, O
where O
the O
entire B
gadd45 I
5 I
" I
- I
UTR I
( I
from I
+ I
1 I
to I
+ I
298 I
) I
or O
a O
45 O
bp O
subfragment O
of O
the O
gadd45 B
5 I
" I
- I
UTR I
( I
from I
+ I
10 I
to I
+ I
55 I
) I
was O
positioned O
at O
the O
5 O
" O
- O
end O
of O

This O
region O
shows O
46 O
% O
identity O
with O
the O
calmodulin B
- I
binding I
region I
of O
rat B
brain I
Ca2 I
+ I
/ I
calmodulin I
- I
dependent I
protein I
kinase I
II I
and O
32 O
% O
identity O
with O
the O
equivalent O
region O
of O
chicken B
smooth I
muscle I
myosin I
light I
chain I
kinase I
. O

In O
CYP7A1 B
transgenic O
mice O
, O
livers O
contained O
approximately O
3 O
- O
fold O
more O
sterol B
response I
element I
- I
binding I
protein I
- I
2 I
mRNA I
. O

Extracellular B
regulated I
kinases I
( I
ERK I
) I
1 I
and O
ERK2 B
are O
authentic O
substrates O
for O
the O
dual B
- I
specificity I
protein I
- I
tyrosine I
phosphatase I
VHR I
. O

The O
7 B
. I
2 I
kb I
EcoRI I
fragment I
of I
AfMNPV I
was O
cloned O
and O
the O
nucleotide O
sequences O
of O
the O
polyhedrin B
coding O
region O
and O
its O
flanking O
regions O
were O
determined O
. O

Immunofluorescence O
obtained O
using O
antibodies O
against O
alphaI B
SigmaI I
/ I
+ I
+ I
betaI I
SigmaI I
spectrin I
and O
Abl B
tyrosine I
kinase I
but O
not O
against O
alphaII B
/ I
betaII I
spectrin I
colocalized O
with O
the O
overexpressed O
green B
fluorescent I
protein I
- O
SH3 B
- I
binding I
protein I
. O

Candidate O
factors O
have O
been O
identified O
by O
the O
observation O
that O
changes O
in O
glucocorticoid O
induction O
parameters O
in O
CV O
- O
1 O
cells O
could O
be O
reproduced O
by O
varying O
the O
cellular O
levels O
of O
coactivators O
[ O
transcriptional B
intermediary I
factor I
2 I
( O
TIF2 B
) O
, O
steroid B
receptor I
coactivator I
1 I
( O
SRC B
- I
1 I
) O
, O
and O
amplified B
in I
breast I
cancer I
1 I
( O
AIB1 B
) O
] O
, O
comodulator O
[ O
CREB B
- I
binding I
protein I
( O
CBP B
) O
] O
, O
or O
corepressor O
[ O
silencing B
mediator I
for I
retinoid I
and I
thyroid I
- I
hormone I
receptors I
( O
SMRT B
) O
] O
without O

Immunoblot O
analyses O
revealed O
that O
the O
loss O
of O
activator O
function O
coincides O
with O
selective O
removal O
of O
the O
C B
- I
terminal I
domain I
( I
CTD I
) I
- I
hyperphosphorylated I
RNAP I
IIO I
along O
with O
NC2 B
. O

The O
Rep78 B
protein I
of O
adeno O
- O
associated O
virus O
( O
AAV O
) O
contains O
amino O
acid O
sequence O
motifs O
common O
to O
rolling B
- I
circle I
replication I
( I
RCR I
) I
initiator I
proteins I
. O

The O
adenovirus B
E1B I
19 I
, I
000 I
- I
molecular I
- I
weight I
( I
19K I
) I
protein I
is O
a O
potent O
inhibitor O
of O
apoptosis O
and O
cooperates O
with O
E1A B
to O
transform O
primary O
rodent O
cells O
. O

Recombinant O
vaccinia O
viruses O
that O
express O
the O
bacteriophage B
T3 I
RNA I
polymerase I
( O
VV B
- I
T3pol I
) O
or O
the O
Escherichia B
coli I
lac I
repressor I
( O
VV B
- I
lacI I
) O
under O
control O
of O
the O
early B
- I
late I
vaccinia I
promoter I
P7 I
. I
5 I
were O
constructed O
. O

Cloning O
, O
sequence O
analysis O
, O
and O
expression O
of O
the O
gene B
encoding I
formaldehyde I
dismutase I
from I
Pseudomonas I
putida I
F61 I
. O

Gene B
1 I
of I
the I
murine I
coronavirus I
, I
MHV I
- I
A59 I
, O
encodes O
approximately O
800 O
kDa O
of O
protein O
products O
within O
two O
overlapping O
open O
reading O
frames O
( O
ORFs O
1a O
and O
1b O
) O
. O

Deletion O
analysis O
of O
the O
7 B
. I
3 I
- I
kb I
GATA I
- I
2 I
promoter I
region I
revealed O
that O
a O
1 O
. O
1 O
- O
kb O
DNA O
sequence O
is O
critical O
for O
expression O
of O
GATA B
- I
2 I
in O
neurons O
. O

These O
data O
suggest O
that O
the O
secreted O
, O
truncated O
receptor O
encoded O
by O
the O
2 B
. I
6 I
- I
kb I
c I
- I
erbB I
transcript I
can O
bind O
to O
TGF B
alpha I
and O
may O
play O
an O
important O
growth O
- O
regulatory O
function O
in O
vitro O
. O

To O
further O
study O
the O
role O
of O
tTG B
in O
liver O
disease O
, O
we O
initiated O
investigations O
into O
the O
effect O
of O
a O
proinflammatory O
mediator O
, O
tumor B
necrosis I
factor I
( I
TNF I
) I
- I
alpha I
, O
on O
tTG B
activity O
in O
cultured O
liver O
cells O
. O

A O
preformed O
SREBP B
- I
1a I
: I
[ I
32P I
] I
DNA I
complex I
bound O
specifically O
to O
membrane O
- O
immobilized O
GST B
- O
CBP B
fusion O
proteins O
that O
contained O
amino O
- O
terminal O
portions O
of O
CBP B
. O

The O
primary O
structures O
of O
the O
human B
KB I
cell I
( I
FR I
- I
KB1 I
) I
folate I
receptor I
( O
FR B
) O
and O
of O
a O
human B
placental I
( I
FR I
- I
P2 I
) I
FR I
, O
proteins O
important O
in O
cellular O
accumulation O
of O
folates O
, O
have O
been O
deduced O
from O
cDNA O
sequences O
. O

The O
primary O
structures O
of O
the O
human B
KB I
cell I
( I
FR I
- I
KB1 I
) I
folate I
receptor I
( O
FR B
) O
and O
of O
a O
human B
placental I
( I
FR I
- I
P2 I
) I
FR I
, O
proteins O
important O
in O
cellular O
accumulation O
of O
folates O
, O
have O
been O
deduced O
from O
cDNA O
sequences O
. O

The O
encoded O
260 B
- I
amino I
- I
acid I
( I
aa I
) I
( I
H1 I
- I
I I
) I
and O
240 B
- I
aa I
( I
H1 I
- I
II I
) I
polypeptides I
possess O
the O
typical O
tripartite O
organization O
of O
animal B
H1 I
histones I
, O
with O
variable O
N O
- O
and O
C O
- O
terminal O
domains O
flanking O
a O
conserved O
' O
globular O
' O
DNA O
- O
binding O
domain O
. O

The O
encoded O
260 B
- I
amino I
- I
acid I
( I
aa I
) I
( I
H1 I
- I
I I
) I
and O
240 B
- I
aa I
( I
H1 I
- I
II I
) I
polypeptides I
possess O
the O
typical O
tripartite O
organization O
of O
animal B
H1 I
histones I
, O
with O
variable O
N O
- O
and O
C O
- O
terminal O
domains O
flanking O
a O
conserved O
' O
globular O
' O
DNA O
- O
binding O
domain O
. O

Two O
human B
beta I
- I
1 I
, I
6 I
- I
N I
- I
acetylglucosaminyltransferases I
forming O
the O
core O
2 O
O O
- O
glycan O
branch O
, O
C2GnT O
and O
the O
I B
antigen I
, O
IGnT B
, O
are O
homologous O
to O
each O
other O
in O
three O
regions O
of O
the O
catalytic O
domain O
( O
A O
, O
B O
, O
C O
) O
and O
their O
genes O
reside O
at O
the O
same O
locus O
, O
chromosome O
9 O
, O
band O
q21 O
( O
Bierhuizen O
, O
M O
. O
F O
. O
A O
. O
, O
Mattei O
, O
M O
. O
- O
G O
. O
and O
Fukuda O
, O
M O
. O
, O
Genes O
Dev O
. O
, O
7 O
, O

Treatment O
with O
H7 O
did O
not O
affect O
IL B
- I
4R I
- O
mediated O
immediate O
signaling O
events O
such O
as O
tyrosine O
phosphorylation O
of O
Jak1 B
, O
Jak3 B
, O
insulin B
receptor I
substrate I
( I
IRS I
) I
- I
1 I
and O
IRS B
- I
2 I
, O
or O
tyrosine O
phosphorylation O
and O
DNA O
binding O
of O
Stat6 B
. O

Hematopoietic B
progenitor I
kinase I
1 I
( O
HPK1 B
) O
is O
a O
member O
of O
the O
mitogen B
- I
activated I
protein I
kinase I
kinase I
kinase I
kinase I
( O
MAP4K B
) O
family O
and O
an O
upstream O
activator O
of O
the O
c B
- I
Jun I
N I
- I
terminal I
kinase I
( O
JNK B
) O
signaling O
cascade O
. O

Genetic O
mutation O
or O
loss O
of O
activin B
/ O
transforming B
growth I
factor I
- I
beta I
( I
TGFbeta I
) I
receptor I
function O
has O
been O
shown O
in O
human O
lymphoid O
, O
breast O
, O
and O
colorectal O
tumors O
as O
well O
as O
Hep2B O
and O
Mv1Lu O
cell O
lines O
. O

We O
now O
describe O
a O
HepG2 B
cell I
casein I
kinase I
II I
beta I
subunit I
cDNA I
of O
2 O
. O
57 O
kb O
containing O
96 O
bases O
of O
5 O
' O
untranslated O
sequence O
, O
645 O
bases O
of O
open O
reading O
frame O
, O
and O
1832 O
bases O
of O
3 O
' O
untranslated O
sequence O
with O
two O
polyadenylation O
consensus O
signal O
sequences O
and O
two O
poly O
( O
A O
) O
stretches O
. O

The O
combined O
in O
vitro O
effects O
of O
ethanol O
wih O
methaqualone O
, O
phenobarbital O
, O
pyrazole O
or O
disulfiram O
were O
studied O
using O
rat B
brain I
microsomal I
NA I
- I
K I
- I
ATPase I
. O

These O
results O
indicate O
that O
the O
2127 O
- O
bp O
cDNA O
encodes O
a O
functional O
feline O
L B
/ I
B I
/ I
K I
- I
type I
ALP I
expressed O
on O
cell O
surfaces O
via O
phosphatidylinositol O
- O
glycan O
linkage O
. O

The O
rec8 B
( I
+ I
) I
, O
rec10 B
( I
+ I
) I
, O
and O
rec11 B
( I
+ I
) I
genes I
of I
the I
fission I
yeast I
Schizosaccharomyces I
pombe I
exhibit O
similar O
specificities O
for O
meiotic O
recombination O
and O
rec8 B
( I
+ I
) I
is O
required O
for O
sister O
chromatid O
cohesion O
and O
homolog O
pairing O
. O

RNA O
determinants O
required O
for O
L4 B
- O
mediated O
attenuation O
control O
of O
the O
S10 B
r I
- I
protein I
operon I
of I
Escherichia I
coli I
. O

The O
human B
CA11 I
gene I
appears O
to O
be O
located O
between O
the O
secretor B
type I
alpha I
( I
1 I
, I
2 I
) I
- I
fucosyltransferase I
gene I
cluster I
( O
FUT1 B
- O
FUT2 B
- O
FUT2P B
) O
and O
the O
D B
- I
site I
binding I
protein I
gene I
( O
DBP B
) O
on O
chromosome O
19q13 O
. O
3 O
. O

NF B
- I
kappaB I
only O
partially O
mediates O
Epstein B
- I
Barr I
virus I
latent I
membrane I
protein I
1 I
activation O
of O
B O
cells O
. O

UVB O
- O
induced O
association O
of O
tumor B
necrosis I
factor I
( I
TNF I
) I
receptor I
1 I
/ O
TNF B
receptor I
- I
associated I
factor I
- I
2 I
mediates O
activation O
of O
Rel B
proteins I
. O

Role O
of O
double B
- I
stranded I
RNA I
- I
dependent I
protein I
kinase I
in O
mediating O
hypersensitivity O
of O
Fanconi O
anemia O
complementation O
group O
C O
cells O
to O
interferon B
gamma I
, O
tumor B
necrosis I
factor I
- I
alpha I
, O
and O
double O
- O
stranded O
RNA O
. O

The O
cDNA O
is O
predicted O
to O
encode O
a O
polypeptide O
of O
298 O
amino O
acids O
that O
is O
homologous O
to O
the O
Y B
- I
box I
( I
inverted I
CCAAT I
) I
family I
of I
DNA I
- I
binding I
transcription I
factors I
. O

However O
, O
in O
each O
case O
in O
which O
either O
the O
DQ B
alpha I
- I
or I
DQ I
beta I
- I
chain I
was O
exchanged O
, O
major O
alterations O
or O
reversals O
of O
this O
pattern O
of O
interaction O
were O
observed O
. O

Although O
IRS B
- I
1 I
, I
- I
2 I
, I
and I
- I
4 I
are O
similar O
in O
overall O
structure O
, O
IRS B
- I
3 I
is O
approximately O
50 O
% O
shorter O
and O
differs O
with O
respect O
to O
sites O
of O
tyrosine O
phosphorylation O
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
CYT B
- I
18 I
with O
a O
small O
RNA O
( O
P4 B
- I
P6 I
RNA I
) O
corresponding O
to O
the O
isolated O
P4 B
- I
P6 I
domain I
of O
the O
N B
. I
crassa I
mitochondrial I
large I
subunit I
ribosomal I
RNA I
intron I
. O

These O
include O
not O
only O
antioxidants O
, O
N B
- I
methyl I
- I
D I
- I
aspartate I
receptor I
antagonists O
, O
inhibitors O
of O
glutamate O
release O
, O
calcium O
channel O
blockers O
, O
polyamine O
antagonists O
, O
and O
nitric B
oxide I
synthase I
inhibitors O
, O
but O
cannabinoids O
, O
aspirin O
, O
melatonin O
, O
and O
vitamin O
B O
- O
12 O
. O

The O
RPC31 B
gene I
encoding O
the O
C31 B
subunit I
of I
Saccharomyces I
cerevisiae I
RNA I
polymerase I
C I
( I
III I
) I
has O
been O
isolated O
, O
starting O
from O
a O
C O
- O
terminal O
fragment O
cloned O
on O
a O
lambda O
gt11 O
library O
. O

Activated B
Ki I
- I
Ras I
suppresses O
12 O
- O
O O
- O
tetradecanoylphorbol O
- O
13 O
- O
acetate O
- O
induced O
activation O
of O
the O
c B
- I
Jun I
NH2 I
- I
terminal I
kinase I
pathway I
in O
human O
colon O
cancer O
cells O
. O

Also O
, O
anti B
- I
HIV I
gp120 I
and O
anti B
- I
CD4 I
crosslinking O
induced O
a O
10 O
- O
15 O
- O
fold O
increase O
in O
levels O
of O
both O
PI B
3 I
- I
and I
PI I
4 I
- I
kinase I
activity O
in O
anti B
- I
CD4 I
precipitates O
. O

Immunoblotting O
using O
a O
phosphospecific B
anti I
- I
Src I
( I
416Y I
) I
antibody I
showed O
a O
ceramide O
- O
induced O
increase O
in O
pp60 B
( O
src B
) O
tyrosine O
phosphorylation O
. O

However O
, O
the O
sequence O
of O
mRAR B
- I
beta I
3 I
region I
A I
differs O
from O
that O
of O
mRAR B
- I
beta I
1 I
by O
an O
additional O
27 O
C O
- O
terminal O
amino O
acids O
encoded O
in O
an O
81 O
nucleotide O
- O
long O
putative O
exon O
which O
is O
spliced O
in O
between O
the O
exons O
encoding O
the O
A B
and I
B I
regions I
of I
mRAR I
- I
beta I
1 I
. O

Identification O
of O
a O
68 B
- I
kilodalton I
nuclear I
ATP I
- I
binding I
phosphoprotein I
encoded O
by O
bovine O
papillomavirus O
type O
1 O
. O

These O
cells O
also O
showed O
an O
increase O
in O
cyclin B
A I
and O
cyclin B
A I
- I
and I
E I
- I
associated I
kinase I
activities O
characteristic O
of O
S O
phase O
induction O
. O

Here O
we O
demonstrate O
that O
the O
T B
cell I
antigen I
receptor I
zeta I
- I
chain I
- I
associated I
ZAP I
- I
70 I
kinase I
and O
T B
cell I
antigen I
receptor I
zeta I
- I
chain I
immunoreceptor I
tyrosine I
- I
based I
activation I
motifs I
are O
essential O
for O
the O
membrane O
recruitment O
of O
SOS B
and O
Vav B
. O

Here O
we O
demonstrate O
that O
the O
T B
cell I
antigen I
receptor I
zeta I
- I
chain I
- I
associated I
ZAP I
- I
70 I
kinase I
and O
T B
cell I
antigen I
receptor I
zeta I
- I
chain I
immunoreceptor I
tyrosine I
- I
based I
activation I
motifs I
are O
essential O
for O
the O
membrane O
recruitment O
of O
SOS B
and O
Vav B
. O

A O
mammalian O
protein O
called O
RFX B
or O
NF B
- I
X I
binds O
to O
the O
X O
box O
( O
or O
X1 O
box O
) O
in O
the O
promoters O
of O
a O
number O
of O
major B
histocompatibility I
( I
MHC I
) I
class I
II I
genes I
. O

The O
structure O
and O
expression O
of O
the O
murine B
gene I
encoding I
granulocyte I
- I
macrophage I
colony I
stimulating I
factor I
: O
evidence O
for O
utilisation O
of O
alternative O
promoters O
. O

Cross O
- O
species O
characterization O
of O
the O
promoter B
region I
of I
the I
cystic I
fibrosis I
transmembrane I
conductance I
regulator I
gene I
reveals O
multiple O
levels O
of O
regulation O
. O

In O
contrast O
, O
a O
similar O
fusion O
protein O
( O
hGH B
- O
LDLR B
- O
DAF17 B
, O
abbreviated O
HLD B
) O
containing O
a O
fragment O
of O
the O
serine O
/ O
threonine O
- O
rich O
domain O
of O
the O
LDL B
receptor I
( O
LDLR B
) O
in O
place O
of O
the O
DAF B
- I
derived I
serine I
/ I
threonine I
- I
rich I
sequences I
, O
does O
not O
become O
GPI O
anchored O
. O

B B
and O
C1 B
fusions I
with O
yeast B
GAL4 I
DNA I
- I
binding I
and I
transcriptional I
activation I
domains I
were O
also O
found O
to O
interact O
when O
synthesized O
and O
assayed O
in O
yeast O
. O

First O
, O
mutations O
in O
the O
IFNgamma B
- I
activated I
sequence I
( O
GAS B
) O
, O
either O
multimerized O
or O
in O
the O
context O
of O
the O
1 B
. I
7 I
- I
kb I
IRF I
- I
1 I
promoter I
, O
failed O
to O
mediate O
a O
PRL B
response O
, O
showing O
that O
the O
IRF B
- I
1 I
GAS B
is O
a O
target O
of O
PRL B
signaling O
. O

Identification O
and O
characterization O
of O
a O
yeast O
gene O
encoding O
the O
U2 B
small I
nuclear I
ribonucleoprotein I
particle I
B I
" I
protein I
. O

Dominant O
- O
negative O
mutations O
in O
the O
G B
- I
protein I
- I
coupled I
alpha I
- I
factor I
receptor I
map O
to O
the O
extracellular O
ends O
of O
the O
transmembrane O
segments O
. O

Acidic O
carboxyl O
- O
terminal O
domain O
of O
gene B
2 I
. I
5 I
protein I
of I
bacteriophage I
T7 I
is O
essential O
for O
protein O
- O
protein O
interactions O
. O

The O
activation O
of O
NF B
- I
kappaB I
- O
dependent O
reporter O
gene O
transcription O
by O
E1A B
was O
potently O
suppressed O
upon O
coexpression O
of O
the O
E1B B
19 I
- I
kDa I
protein I
( I
19K I
) I
. O

The O
myeloid B
zinc I
finger I
gene I
1 I
( O
MZF1 B
) O
encodes O
a O
C B
( I
2 I
) I
H I
( I
2 I
) I
zinc I
finger I
transcription I
factor I
that O
regulates O
granulopoiesis O
and O
may O
have O
a O
regulatory O
role O
in O
cellular O
proliferation O
and O
oncogenesis O
. O

Influenza O
virus O
- O
induced O
NF B
- I
kappaB I
- I
dependent I
gene I
expression O
is O
mediated O
by O
overexpression O
of O
viral O
proteins O
and O
involves O
oxidative O
radicals O
and O
activation O
of O
IkappaB B
kinase I
. O

The O
NF B
- I
kappaB I
/ O
Rel B
transcription O
factors O
participate O
in O
the O
activation O
of O
immune O
system O
regulatory O
genes O
and O
viral B
early I
genes I
including O
the O
human B
immunodeficiency I
virus I
type I
1 I
long I
terminal I
repeat I
. O

Regulation O
of O
activating B
transcription I
factor I
- I
1 I
and O
the O
cAMP B
response I
element I
- I
binding I
protein I
by O
Ca2 B
+ I
/ I
calmodulin I
- I
dependent I
protein I
kinases I
type I
I I
, I
II I
, I
and I
IV I
. O

Immunoblotting O
showed O
that O
both O
the O
( O
1 O
- O
404 O
) O
- O
peptide O
and O
( O
1 O
- O
506 O
) O
- O
peptide O
are O
recognized O
by O
95J10 B
, O
a O
monoclonal O
antibody O
that O
was O
previously O
raised O
against O
perlecan B
- I
( I
24 I
- I
404 I
) I
- I
peptide I
expressed O
in O
Escherichia O
coli O
. O

To O
gain O
further O
insights O
into O
these O
events O
, O
the O
porcine B
G I
alpha I
i I
- I
3 I
gene I
minimal I
promoter I
was O
characterized O
and O
found O
67 O
base O
pairs O
upstream O
from O
the O
major O
transcription O
start O
site O
. O

Similarly O
, O
antisense B
TGF I
- I
beta I
type I
II I
receptor I
oligodeoxynucleotides I
( I
40 I
microM I
) I
resulted O
in O
a O
58 O
% O
increase O
in O
branching O
, O
compared O
to O
scrambled O
and O
mismatched O
sequence O
controls O
, O
while O
TGF B
- I
beta I
, I
type I
II I
receptor I
mRNA I
and O
its O
protein O
expression O
levels O
were O
suppressed O
by O
95 O
and O
84 O
% O
, O
respectively O
. O

Similarly O
, O
antisense B
TGF I
- I
beta I
type I
II I
receptor I
oligodeoxynucleotides I
( I
40 I
microM I
) I
resulted O
in O
a O
58 O
% O
increase O
in O
branching O
, O
compared O
to O
scrambled O
and O
mismatched O
sequence O
controls O
, O
while O
TGF B
- I
beta I
, I
type I
II I
receptor I
mRNA I
and O
its O
protein O
expression O
levels O
were O
suppressed O
by O
95 O
and O
84 O
% O
, O
respectively O
. O

In O
this O
report O
we O
describe O
the O
structure O
and O
DNA O
sequence O
of O
transcriptional O
control O
regions O
from O
both O
human B
and I
Wistar I
- I
rat I
single I
copy I
EGF I
genes I
and O
their O
functional O
analysis O
in O
epithelial O
cell O
cultures O
. O

Biochemical O
studies O
have O
identified O
a O
cellular O
non B
- I
P I
element I
- I
encoded I
DNA I
binding I
protein I
, O
termed O
the O
inverted B
repeat I
binding I
protein I
( O
IRBP B
) O
, O
that O
specifically O
interacts O
with O
the O
outer O
half O
of O
the O
31 O
- O
bp O
terminal O
inverted O
repeats O
. O

The O
c B
- I
raf I
- I
1 I
proto I
- I
oncogene I
is O
the O
cellular B
homologue I
of I
v I
- I
raf I
, O
the O
oncogene O
of O
the O
acutely O
transforming O
retrovirus O
3611 O
- O
MSV O
. O

The O
traW B
gene I
of I
the I
Escherichia I
coli I
K I
- I
12 I
sex I
factor I
, O
F O
, O
encodes O
one O
of O
the O
numerous O
proteins O
required O
for O
conjugative O
transfer O
of O
this O
plasmid O
. O

Adenovirus O
infection O
of O
hepatoma O
cells O
inhibited O
transcription O
of O
the O
phosphoenolpyruvate B
carboxykinase I
( O
GTP O
) O
( O
EC B
4 I
. I
1 I
. I
1 I
. I
32 I
) O
( O
PEPCK B
) O
gene O
and O
virtually O
eliminated O
transcription O
of O
a O
chimeric O
gene O
which O
contained O
the O
PEPCK B
promoter I
linked O
to O
the O
structural O
gene O
for O
chloramphenicol B
acetyltransferase I
( O
CAT B
) O
. O

Expression O
of O
the O
gene O
encoding O
transcription B
factor I
cyclic I
adenosine I
3 I
' I
, I
5 I
' I
- I
monophosphate I
( I
cAMP I
) I
response I
element I
- I
binding I
protein I
( O
CREB B
) O
: O
regulation O
by O
follicle B
- I
stimulating I
hormone I
- O
induced O
cAMP O
signaling O
in O
primary O
rat O
Sertoli O
cells O
. O

( O
i O
) O
The O
chimeric O
gene O
consisting O
of O
the O
coding O
and O
5 O
' O
nontranslated O
leader O
regions O
of O
the O
TK B
gene I
fused O
to O
portions O
of O
the O
domain O
of O
alpha B
gene I
0 I
extending O
largely O
upstream O
from O
the O
site O
of O
initiation O
of O
transcription O
of O
alpha B
gene I
0 I
was O
regulated O
in O
the O
same O
fashion O
as O
the O
alpha B
4 I
- I
and I
alpha I
27 I
- I
TK I
chimeras O
. O

A O
procaryotic O
regulatory O
factor O
with O
a O
histone B
H1 I
- I
like I
carboxy I
- I
terminal I
domain I
: O
clonal O
variation O
of O
repeats O
within O
algP B
, O
a O
gene O
involved O
in O
regulation O
of O
mucoidy O
in O
Pseudomonas O
aeruginosa O
. O

This O
incompatibility O
phenotype O
requires O
the O
global O
transcriptional O
repressor O
, O
KorB B
, O
and O
the O
target O
for O
incC B
- O
mediated O
incompatibility O
is O
a O
KorB B
- I
binding I
site I
( I
O I
( I
B I
) I
) I
. O

The O
infection O
of O
cells O
with O
Moloney O
murine O
leukemia O
virus O
( O
M O
- O
MuLV O
) O
causes O
an O
increase O
in O
specific O
cellular O
gene O
products O
, O
including O
the O
major B
histocompatibility I
complex I
( I
MHC I
) I
class I
I I
antigens I
. O

This O
unusual O
behaviour O
may O
be O
explained O
by O
the O
18 B
amino I
acid I
- I
long I
CDR I
- I
H3 I
and O
could O
be O
of O
value O
in O
the O
design O
of O
' O
single O
domain O
' O
antibodies O
. O

The O
metalloproteinase B
mediating O
Met B
cleavage O
was O
specifically O
inhibited O
by O
the O
tissue B
inhibitor I
of I
metalloproteinases I
( I
TIMP I
) I
- I
3 I
, O
but O
not O
by O
TIMP B
- I
1 I
or O
TIMP B
- I
2 I
. O

The O
clr1 B
locus I
regulates O
the O
expression O
of O
the O
cryptic B
mating I
- I
type I
loci I
of I
fission I
yeast I
. O

We O
have O
characterized O
a O
new O
cDNA O
, O
33k O
- O
6 O
, O
potentially O
encoding O
a O
tobacco B
33 I
kDa I
chloroplast I
RNP I
( I
cp33 I
) I
homologue I
. O

The O
gamma B
- I
GCS I
gene I
is O
expressed O
ubiquitously O
and O
induced O
coordinately O
with O
NAD B
( I
P I
) I
H I
: I
quinone I
oxidoreductase I
( I
1 I
) I
( O
NQO1 B
) O
and O
glutathione B
S I
- I
transferase I
Ya I
( O
GST B
Ya I
) O
in O
response O
to O
xenobiotics O
and O
antioxidants O
. O

The O
1031 B
- I
bp I
wild I
- I
type I
HIT1 I
DNA I
which O
contained O
an O
open O
reading O
frame O
encoding O
a O
protein O
of O
164 O
amino O
acids O
and O
the O
AGG B
arginine I
tRNA I
gene I
complemented O
all O
hit1 B
- I
1 I
mutant I
phenotypes I
, O
indicating O
that O
the O
mutant O
phenotypes O
were O
caused O
by O
the O
deletion O
of O
these O
genes O
. O

Here O
, O
we O
analyzed O
the O
interaction O
of O
the O
Lactococcus B
lactis I
Ll I
. I
LtrB I
group I
II I
intron I
endonuclease I
with O
its O
DNA O
target O
site O
by O
DNA O
footprinting O
and O
modification O
- O
interference O
approaches O
. O

Expression O
of O
the O
bacteriophage B
T4 I
DNA I
terminase I
genes I
16 I
and I
17 I
yields O
multiple O
proteins O
. O

Upstream O
tissue B
inhibitor I
of I
metalloproteinases I
- I
1 I
( I
TIMP I
- I
1 I
) I
element I
- I
1 I
, O
a O
novel O
and O
essential O
regulatory O
DNA O
motif O
in O
the O
human B
TIMP I
- I
1 I
gene I
promoter I
, O
directly O
interacts O
with O
a O
30 O
- O
kDa O
nuclear O
protein O
. O

